• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

工程化表面用于特异性诱导小鼠胚胎干细胞的血管分化。

Engineering surfaces for site-specific vascular differentiation of mouse embryonic stem cells.

机构信息

Institute of Biomaterials and Biomedical Engineering, University of Toronto, Ont., Canada.

出版信息

Acta Biomater. 2010 Jun;6(6):1904-16. doi: 10.1016/j.actbio.2009.12.005. Epub 2009 Dec 11.

DOI:10.1016/j.actbio.2009.12.005
PMID:20004260
Abstract

Differentiation of stem and progenitor cells routinely relies on the application of soluble growth factors, an approach that enables temporal control of cell fate but enables no spatial control of the differentiation process. Angiogenic progenitor cells derived from mouse embryonic stem cells (ESCs) were differentiated here according to the pattern of immobilized vascular endothelial growth factor-A (VEGF). Mouse ESCs engineered to express green fluorescent protein (eGFP) under control of promoter for the receptor tyrosine kinase Flk1 were used. The Flk1+ angiogenic progenitors were selected from day 3 differentiating embryoid bodies based on their expression of eGFP using fluorescence activated cell sorting. Mouse VEGF(165) was covalently immobilized onto collagen IV (ColIV) using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) chemistry. A non-cell adhesive layer of photocrosslinkable chitosan was first created, after which VEGF-ColIV was stamped as 100mum wide lanes on top of the chitosan layer and the Flk1+ angiogenic progenitors were seeded for site-specific differentiation. Lanes stamped with only ColIV served as controls. The results presented here demonstrate that the cultivation of Flk1+ progenitors on surfaces with immobilized VEGF yielded primarily endothelial cells (53+/-13% CD31 positive and 17+/-2% smooth muscle actin positive), whereas surfaces without VEGF favored vascular smooth muscle-like cell differentiation (26+/-17% CD31 positive and 38+/-9% smooth muscle actin positive).

摘要

常规的干细胞和祖细胞的分化依赖于可溶性生长因子的应用,这种方法可以实现对细胞命运的时间控制,但不能实现分化过程的空间控制。本文根据固定的血管内皮生长因子-A(VEGF)模式,从小鼠胚胎干细胞(ESCs)中分化出血管生成祖细胞。使用的是受受体酪氨酸激酶 Flk1 启动子控制表达绿色荧光蛋白(eGFP)的工程化小鼠 ESC。Flk1+血管生成祖细胞根据其表达的 eGFP ,在第 3 天分化的胚状体中通过荧光激活细胞分选进行分选。使用 1-乙基-3-(3-二甲基氨基丙基)碳二亚胺(EDC)化学将小鼠 VEGF(165)共价固定在胶原蛋白 IV(ColIV)上。首先创建一个非细胞粘附的光交联壳聚糖层,然后将 VEGF-ColIV 作为 100μm 宽的条带压印在壳聚糖层的顶部,并接种 Flk1+血管生成祖细胞进行特异性分化。仅压印 ColIV 的条带作为对照。本文结果表明,将 Flk1+祖细胞培养在固定 VEGF 的表面上主要产生内皮细胞(53+/-13% CD31 阳性和 17+/-2%平滑肌肌动蛋白阳性),而没有 VEGF 的表面则有利于血管平滑肌样细胞分化(26+/-17% CD31 阳性和 38+/-9%平滑肌肌动蛋白阳性)。

相似文献

1
Engineering surfaces for site-specific vascular differentiation of mouse embryonic stem cells.工程化表面用于特异性诱导小鼠胚胎干细胞的血管分化。
Acta Biomater. 2010 Jun;6(6):1904-16. doi: 10.1016/j.actbio.2009.12.005. Epub 2009 Dec 11.
2
VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering.VEGF 诱导人胚胎干细胞分化为功能性内皮细胞:对组织工程的影响。
Arterioscler Thromb Vasc Biol. 2010 Jan;30(1):80-9. doi: 10.1161/ATVBAHA.109.194233. Epub 2009 Oct 29.
3
Endothelial progenitor populations in differentiating embryonic stem cells I: Identification and differentiation kinetics.分化中的胚胎干细胞中的内皮祖细胞群体 I:鉴定和分化动力学。
Tissue Eng Part A. 2009 Dec;15(12):3709-18. doi: 10.1089/ten.TEA.2008.0659.
4
Endothelial progenitor populations in differentiating embryonic stem cells. II. Drug selection and functional characterization.分化胚胎干细胞中的内皮祖细胞群体。II. 药物选择和功能表征。
Tissue Eng Part A. 2010 Mar;16(3):1065-74. doi: 10.1089/ten.TEA.2009.0295.
5
Leptin enhances endothelial cell differentiation and angiogenesis in murine embryonic stem cells.瘦素可增强小鼠胚胎干细胞中的内皮细胞分化和血管生成。
Microvasc Res. 2015 Jan;97:65-74. doi: 10.1016/j.mvr.2014.09.004. Epub 2014 Sep 22.
6
ROCK suppression promotes differentiation and expansion of endothelial cells from embryonic stem cell-derived Flk1(+) mesodermal precursor cells.ROCK 抑制促进了胚胎干细胞来源的 Flk1(+)中胚层前体细胞向血管内皮细胞的分化和扩增。
Blood. 2012 Sep 27;120(13):2733-44. doi: 10.1182/blood-2012-04-421610. Epub 2012 Aug 14.
7
Defining conditions for covalent immobilization of angiogenic growth factors onto scaffolds for tissue engineering.定义将血管生成生长因子共价固定在组织工程支架上的条件。
J Tissue Eng Regen Med. 2011 Jan;5(1):69-84. doi: 10.1002/term.292. Epub 2010 Aug 17.
8
Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo.从人类胚胎干细胞中分离出的血管祖细胞可分化为内皮细胞和平滑肌样细胞,并在体内形成血管网络。
Circ Res. 2007 Aug 3;101(3):286-94. doi: 10.1161/CIRCRESAHA.107.150201. Epub 2007 Jun 14.
9
A hierarchical order of factors in the generation of FLK1- and SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells.从胚胎干细胞生成表达FLK1和SCL的造血及内皮祖细胞过程中各因素的层次顺序。
Development. 2004 Jun;131(11):2749-62. doi: 10.1242/dev.01130.
10
Temporal specification of blood progenitors from mouse embryonic stem cells and induced pluripotent stem cells.从鼠胚胎干细胞和诱导多能干细胞中产生的血液祖细胞的时间特异性。
Development. 2010 Sep 1;137(17):2829-39. doi: 10.1242/dev.042119. Epub 2010 Jul 21.

引用本文的文献

1
Harnessing the Power of Induced Pluripotent Stem Cells and Gene Editing Technology: Therapeutic Implications in Hematological Malignancies.利用诱导多能干细胞和基因编辑技术的力量:血液系统恶性肿瘤的治疗意义。
Cells. 2021 Oct 9;10(10):2698. doi: 10.3390/cells10102698.
2
Biomaterial Engineering for Controlling Pluripotent Stem Cell Fate.用于控制多能干细胞命运的生物材料工程
Stem Cells Int. 2018 Dec 5;2018:9068203. doi: 10.1155/2018/9068203. eCollection 2018.
3
Control of stem cell fate by engineering their micro and nanoenvironment.
通过构建干细胞的微纳米环境来控制其命运
World J Stem Cells. 2015 Jan 26;7(1):37-50. doi: 10.4252/wjsc.v7.i1.37.
4
Inhibition of apoptosis in human induced pluripotent stem cells during expansion in a defined culture using angiopoietin-1 derived peptide QHREDGS.使用血管生成素-1衍生肽QHREDGS在特定培养条件下扩增人诱导多能干细胞时对细胞凋亡的抑制作用
Biomaterials. 2014 Sep;35(27):7786-99. doi: 10.1016/j.biomaterials.2014.05.018. Epub 2014 Jun 13.
5
Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.控制释放策略在骨、软骨和骨软骨工程中的应用 - 第二部分:从单一到多种生物活性因子传递的演变所面临的挑战。
Tissue Eng Part B Rev. 2013 Aug;19(4):327-52. doi: 10.1089/ten.TEB.2012.0727. Epub 2013 Jan 30.
6
The application of three-dimensional collagen-scaffolds seeded with myoblasts to repair skeletal muscle defects.接种成肌细胞的三维胶原蛋白支架在修复骨骼肌缺损中的应用。
J Biomed Biotechnol. 2011;2011:812135. doi: 10.1155/2011/812135. Epub 2011 Dec 12.
7
Bioactive scaffolds for engineering vascularized cardiac tissues.用于构建血管化心脏组织工程的生物活性支架
Macromol Biosci. 2010 Nov 10;10(11):1286-301. doi: 10.1002/mabi.201000202.